228 related articles for article (PubMed ID: 37046073)
1. In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity.
Müller FA; Stamou M; Englert FH; Frenzel O; Diedrich S; Suter-Dick L; Wambaugh JF; Sturla SJ
Arch Toxicol; 2023 Jun; 97(6):1701-1721. PubMed ID: 37046073
[TBL] [Abstract][Full Text] [Related]
2. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay.
Brecklinghaus T; Albrecht W; Duda J; Kappenberg F; Gründler L; Edlund K; Marchan R; Ghallab A; Cadenas C; Rieck A; Vartak N; Tolosa L; Castell JV; Gardner I; Halilbasic E; Trauner M; Ullrich A; Zeigerer A; Demirci Turgunbayer Ö; Damm G; Seehofer D; Rahnenführer J; Hengstler JG
Toxicol Lett; 2022 Sep; 368():33-46. PubMed ID: 35963427
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans.
Goda K; Kobayashi A; Takahashi A; Takahashi T; Saito K; Maekawa K; Saito Y; Sugai S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417920
[TBL] [Abstract][Full Text] [Related]
4. Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug-induced liver injury.
Allard J; Bucher S; Ferron PJ; Launay Y; Fromenty B
Fundam Clin Pharmacol; 2024 Feb; 38(1):152-167. PubMed ID: 37665028
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved.
Martínez-Sena T; Moro E; Moreno-Torres M; Quintás G; Hengstler J; Castell JV
Arch Toxicol; 2023 Jun; 97(6):1723-1738. PubMed ID: 37022445
[TBL] [Abstract][Full Text] [Related]
6. A biologically based model to quantitatively assess the role of the nuclear receptors liver X (LXR), and pregnane X (PXR) on chemically induced hepatic steatosis.
Bay C; El-Masri HA
Toxicol Lett; 2022 Apr; 359():46-54. PubMed ID: 35143881
[TBL] [Abstract][Full Text] [Related]
7. Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis.
Tolosa L; Gómez-Lechón MJ; Jiménez N; Hervás D; Jover R; Donato MT
Toxicol Appl Pharmacol; 2016 Jul; 302():1-9. PubMed ID: 27089845
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models.
Vitins AP; Kienhuis AS; Speksnijder EN; Roodbergen M; Luijten M; van der Ven LT
Arch Toxicol; 2014 Aug; 88(8):1573-88. PubMed ID: 24535564
[TBL] [Abstract][Full Text] [Related]
9. Estimating provisional margins of exposure for data-poor chemicals using high-throughput computational methods.
Nicolas CI; Linakis MW; Minto MS; Mansouri K; Clewell RA; Yoon M; Wambaugh JF; Patlewicz G; McMullen PD; Andersen ME; Clewell Iii HJ
Front Pharmacol; 2022; 13():980747. PubMed ID: 36278238
[TBL] [Abstract][Full Text] [Related]
10. QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis.
Gadaleta D; Manganelli S; Roncaglioni A; Toma C; Benfenati E; Mombelli E
J Chem Inf Model; 2018 Aug; 58(8):1501-1517. PubMed ID: 29949360
[TBL] [Abstract][Full Text] [Related]
11. Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways.
AbdulHameed MDM; Pannala VR; Wallqvist A
Front Genet; 2019; 10():1007. PubMed ID: 31681434
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.
Rodrigues RM; Branson S; De Boe V; Sachinidis A; Rogiers V; De Kock J; Vanhaecke T
Arch Toxicol; 2016 Mar; 90(3):677-89. PubMed ID: 25716160
[TBL] [Abstract][Full Text] [Related]
13. B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals.
Leitch AC; Probert PME; Shayman JA; Meyer SK; Kass GEN; Wright MC
Toxicology; 2017 Jul; 386():120-132. PubMed ID: 28552552
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates.
Donato MT; Gómez-Lechón MJ
Curr Drug Metab; 2012 Oct; 13(8):1160-73. PubMed ID: 22746303
[TBL] [Abstract][Full Text] [Related]
15. Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.
Luckert C; Braeuning A; de Sousa G; Durinck S; Katsanou ES; Konstantinidou P; Machera K; Milani ES; Peijnenburg AACM; Rahmani R; Rajkovic A; Rijkers D; Spyropoulou A; Stamou M; Stoopen G; Sturla S; Wollscheid B; Zucchini-Pascal N; Lampen A
Chem Res Toxicol; 2018 Aug; 31(8):784-798. PubMed ID: 29995386
[TBL] [Abstract][Full Text] [Related]
16. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
[TBL] [Abstract][Full Text] [Related]
17. A Multi-Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug-Induced Steatosis in Liver Cells in Culture.
Tolosa L; Gómez-Lechón MJ; Donato MT
Curr Protoc Toxicol; 2017 May; 72():14.15.1-14.15.11. PubMed ID: 28463417
[TBL] [Abstract][Full Text] [Related]
18. Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing.
Wetmore BA; Wambaugh JF; Allen B; Ferguson SS; Sochaski MA; Setzer RW; Houck KA; Strope CL; Cantwell K; Judson RS; LeCluyse E; Clewell HJ; Thomas RS; Andersen ME
Toxicol Sci; 2015 Nov; 148(1):121-36. PubMed ID: 26251325
[TBL] [Abstract][Full Text] [Related]
19. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
[TBL] [Abstract][Full Text] [Related]
20. Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis.
Angrish MM; Kaiser JP; McQueen CA; Chorley BN
Toxicol Sci; 2016 Apr; 150(2):261-8. PubMed ID: 26980302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
